Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple nerve block transform heart surgery recovery?

NCT ID NCT07785323

Symptom relief Sponsor: Burak Çilingir Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time

Summary

This trial tests whether a targeted nerve block, called a serratus posterior superior intercostal plane (SPSIP) block, can improve recovery after cardiac surgery. Half of the 50 adult participants will receive the block with a local anesthetic during surgery, while the other half will not. Researchers will measure pain levels, opioid use, and overall quality of recovery in the days after surgery to see if the block offers meaningful benefits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Serratus posterior superior intercostal plane (SPSIP) block with bupivacaine
What this could lead to
If effective, this nerve block could become a standard way to ease pain and speed recovery after cardiac surgery, reducing the need for opioids.
What could go wrong
This is a small, early-stage trial, so results may not apply to all patients. The block carries risks like infection, bleeding, or allergic reaction, and may not improve recovery as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18-80 years * Patients scheduled for elective cardiac surgery * American Society of Anesthesiologists (ASA) physical status III--IV * Patients who provide written informed consent to participate in the study Exclusion Criteria: * Patient refusal to participate in the study * Known allergy to local anesthetics * Infection at the site of block application * Coagulopathy or contraindication to regional anesthesia * Emergency surgery * Patients unable to communicate adequately or complete the study assessments

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac surgery are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac surgery Postoperative pain Postoperative recovery after cardiac surgery

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Adıyaman Training and Research Hospital

    Adıyaman, 02100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.